← SynDRA
cyclovirobuxin.d
SynDRA canonical compound SYN1970429 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Mechanism of action | calcium channel modulator |
Mechanisms of action (all sources)
- calcium channel modulator
Cross-references
Synonyms
- Cyclovirobuxine-D
- Cyclovirobuxine
- Cyclovirobuxin D
- Bebuxine
- CVB-D
- NSC-91722
- (1S,3R,6S,8R,11S,12S,14R,15S,16R)-7,7,12,16-tetramethyl-6-(methylamino)-15-[(1S)-1-(methylamino)ethyl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecan-14-ol
- 51GY352868
- (1R,3R,6S,8R,11S,12S,14R,15S,16R)-7,7,12,16-Tetramethyl-6-(methylamino)-15-[(1S)-1-(methylamino)ethyl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecan-14-ol
- CyclovirobuxineD
- UNII-51GY352868
- CYCLOVIROBUXINUM D
- Cyclovirobuxin D (Bebuxine)
- HUANWEIHUANGYANGXING D
- CYCLOVIROBUXINE [INCI]
- SCHEMBL3385409
- CHEMBL3348842
- CYCLOVIROBUXINUM D [CHP]
- DTXSID801316983
- CYCLOVIROBUXINE D [WHO-DD]
- HY-N0107
- NSC91722
- ZINC4919236
- MFCD00468040
- s2402
- AKOS015896107
- NCGC00346606-01
- NCGC00346606-02
- 9,19-Cyclopregnan-16-ol, 4,4,14-trimethyl-3,20-bis(methylamino)-, (3beta,5alpha,16alpha,20S)-
- AS-17717
- CS-0007794
- 860C797
- Q-100865
- Q27260897
- 4,4,14-Trimethyl-3alpha,20-bis(methylamino)-9,19-cyclo-5alpha-pregnan-16-ol
- 9,19-Cyclopregnan-16-ol, 4,4,14-trimethyl-3,20-bis(methylamino)-,(3b,5a,16a,20S)-
- 9,19-Cyclo-5-alpha,9-beta-pregnan-16-alpha-ol, 4,4,14-trimethyl-3-beta,20-alpha-bis(methylamino)-
- 9,19-CYCLO-5.ALPHA.,9.BETA.-PREGNAN-16.ALPHA.-OL, 4,4,14-TRIMETHYL-3.BETA.,20.ALPHA.-BIS(METHYLAMINO)-
- 9,19-CYCLOPREGNAN-16-OL, 4,4,14-TRIMETHYL-3,20-BIS(METHYLAMINO)-, (3.BETA.,5.ALPHA.,16.ALPHA.,20S)-
Look up cyclovirobuxin.d in the interactive SynDRA portal →